Kodiak Sciences Inc   Report issue

For profit Phase 3
Founded: Palo Alto CA United States (2009)

Organization Overview

First Clinical Trial
2018
NCT03790852
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Kodiak Sciences Inc